All changes for the tissue liver and biliary system (8)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1060
Blood flow to liver decreases
Physiological
liver
Human
—
—
DAA594
Cancer of liver and intrahepatic bile ducts
Pathological
liver
Human
—
SeriesMorbidity
DAA638
Cholelithiasis and other disorders of gallbladders
Pathological
liver and biliary system
Human
—
SeriesMorbidity
DAA637
Chronic liver disease and cirrhosis
Pathological
liver
Human
—
SeriesMorbidity
DAA2590
Loss of liver regeneration with age
Physiological
liver
Human
—
—
DAA849
telomere shortening
Molecular
liver
Human
—
—
DAA1061
Variability in clearance of hepatically metabolized drugs
Physiological
liver
Human
—
—
DAA588
Viral hepatitis
Pathological
liver
Human
—
SeriesMorbidity
| Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
|---|---|---|---|---|---|---|---|
| DAA1060 | Blood flow to liver decreases | Physiological | liver | Human | — | — | |
| DAA594 | Cancer of liver and intrahepatic bile ducts | Pathological | liver | Human | — | SeriesMorbidity | |
| DAA638 | Cholelithiasis and other disorders of gallbladders | Pathological | liver and biliary system | Human | — | SeriesMorbidity | |
| DAA637 | Chronic liver disease and cirrhosis | Pathological | liver | Human | — | SeriesMorbidity | |
| DAA2590 | Loss of liver regeneration with age | Physiological | liver | Human | — | — | |
| DAA849 | telomere shortening | Molecular | liver | Human | — | — | |
| DAA1061 | Variability in clearance of hepatically metabolized drugs | Physiological | liver | Human | — | — | |
| DAA588 | Viral hepatitis | Pathological | liver | Human | — | SeriesMorbidity |